ZMIZ2 and acute myeloid leukemia: LINC00265 helps ZMIZ2 to stabilize β-catenin by acting as a sponge (and thereby inhibiting several miRNAs) in colorectal cancer (Zhu et al., 2019), and it can be used to predict poor prognosis in acute myeloid leukemia patients (Ma et al., 2018).